Cellphire has a total of 153 patents globally, out of which 17 have been granted. Of these 153 patents, more than 63% patents are active. The United States of America is where Cellphire has filed the maximum number of patents, followed by Canada and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cellphire.
Cellphire was founded in 2005. Cellphire develops technology to stabilize cells for various medical applications, from treating trauma to wound care, imaging, drug delivery, and diagnostics. Their technology ensures a steady supply of cells for medical use, particularly in managing bleeding casualties.
Do read about some of the most popular patents of Cellphire which have been covered by us in this article and also you can find Cellphire patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cellphire patent portfolio.
How many patents does Cellphire have?
Cellphire has a total of 153 patents globally. These patents belong to 30 unique patent families. Out of 153 patents, 97 patents are active.
How Many Patents did Cellphire File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Cellphire Applications Filed | Cellphire Patents Granted |
2023 | 5 | 4 |
2022 | 21 | 2 |
2021 | 22 | – |
2020 | 36 | 1 |
2019 | 27 | 1 |
2018 | 7 | – |
2017 | 6 | – |
2016 | 13 | 1 |
2015 | 2 | – |
How many Cellphire patents are Alive/Dead?
Worldwide Patents
How Many Patents did Cellphire File in Different Countries?
Countries in which Cellphire Filed Patents
Country | Patent |
United States of America | 44 |
Canada | 21 |
Europe (EPO) | 16 |
Australia | 14 |
Hong Kong (S.A.R.) | 6 |
Israel | 5 |
Singapore | 3 |
Brazil | 3 |
South Africa | 2 |
China | 2 |
Taiwan | 2 |
Korea (South) | 2 |
New Zealand | 1 |
Germany | 1 |
Austria | 1 |
Japan | 1 |
India | 1 |
Where are Research Centers of Cellphire Patents Located?
10 Best Cellphire Patents
US20060035383A1 is the most popular patent in the Cellphire portfolio. It has received 32 citations so far from companies like Medtronic Vascular, I.M.T. Interface Multigrad Technology.
Below is the list of 10 most cited patents of Cellphire:
Publication Number | Citation Count |
US20060035383A1 | 32 |
US7811558B2 | 29 |
US8097403B2 | 27 |
US20060051731A1 | 22 |
US20110183311A1 | 20 |
US8486617B2 | 17 |
WO2017040238A1 | 13 |
US20220168353A1 | 8 |
WO2020227149A1 | 7 |
WO2016201081A1 | 7 |
What Percentage of Cellphire US Patent Applications Were Granted?
Cellphire (Excluding its subsidiaries) has filed 34 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 30%.
Below are the key stats of Cellphire patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Cellphire?
Law Firm | Total Applications | Success Rate |
Double Helix Law Mannyv Ip | 24 | 46.15% |
Greenblum & Bernstein Plc | 5 | 0.00% |
Fish & Richardson | 4 | 0.00% |
Latimer IP Law Llc | 1 | 0.00% |
What are Cellphire key innovation segments?
What Technologies are Covered by Cellphire?
The chart below distributes patents filed by Cellphire